Analytics

Feliza Mirasol is the science editor for 

Articles

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

Jorie Kassel is Laboratory Division Manager at Particle Technology Labs.

Image analysis is crucial for particle analysis of complex finished drug products.

Using Image Analysis to Differentiate Particle Size and Shape in Drug Products with Multiple Components 

Karin Kottig, PhD, is head of Contract Service Analytics, Vetter Development Service.

Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.

Stability Studies: An Essential Step for Quality Management in Drug Development

Shailesh Vengurlekar is senior vice-president, Quality and Regulatory Affairs, at LGM Pharma.

By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling. 

Establishing a Framework for Reliable Pharma Labeling

TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.

TAU Systems to Establish TAU Labs, a New Laser Plasma Accelerator Application Center

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.

Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development

Twist Bioscience now offers its Express Genes rapid gene synthesis service at its Wilsonville, Ore., manufacturing facility.

Twist Bioscience Launches Gene Synthesis Service

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation highlights the company’s motivation behind their new bioanalysis kit for oligonucleotides.

The Need for New Bioanalysis Technology (AAPS PharmSci 360)

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation discusses the analytical and downstream purification challenges of oligonucleotides.

Analytical Method Development